Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer

The pRb (p16-pRb-cyclin D1) and p53 (p53-MDM2-p21) pathways play a critical role in tumorigenesis. To evaluate which of these cell cycle regulatory proteins are related to patients' prognosis, a comprehensive analysis of alterations in these components, was carried out in 100 ESCCs (oesophageal squamous cell carcinoma) using immunohistochemistry and correlated with clinicopathological parameters by univariate analysis. Overexpression of p53. MDM2 and cyclin D1 proteins was observed in 73, 42 and 67% of the cases, respectively, while loss of expression of p21, p16 and pRb was observed in 36, 45 and 75% of the cases, respectively. Multiple logistic regression analysis revealed that loss of p16 inmunoreactivity, vas a significant risk factor For tumour stage (pT) (Odds Ratio (OR) 3.3), whereas the loss of pRb was a significant risk factor for nodal metastasis (pN) (OR = 8.8). MDM2 overexpression emerged as the most significant risk Factor for distant organ metastasis (pM) (OR - 4.6). Of the ESCC patients who underwent oesophagectomy, 50 cases ere followed-up for a maximum period of 44 months and median of 16 month. Survival analysis revealed that Cyclin D1 overexpression is an adverse prognosticator for disease-free survival, as well as overall survival, and tumour stage (pT) is an adverse prognosticator for disease-free survival. In conclusion, these data support a model of oesophageal cancer pathogenesis in which both the pRb and p53 pathways Lire inactivated and suggests an in-depth evaluation of the clinical utility of these putative markers is warranted. (C) 2002 Published by Elsevier Science Ltd.